This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
KKR Real Estate Finance (KREF) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
KKR Real Estate (KREF) delivered earnings and revenue surprises of 17.07% and 5.23%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Great Ajax (AJX) Surges 5.3%: Is This an Indication of Further Gains?
by Zacks Equity Research
Great Ajax (AJX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
NexPoint (NREF) Is a Great Choice for "Trend" Investors, Here's Why
by Zacks Equity Research
If you are looking for stocks that are well positioned to maintain their recent uptrend, NexPoint (NREF) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
Has BancFirst (BANF) Outpaced Other Finance Stocks This Year?
by Zacks Equity Research
Here is how BancFirst (BANF) and NexPoint (NREF) have performed compared to their sector so far this year.
NexPoint (NREF) Q1 Earnings and Revenues Beat Estimates
by Zacks Equity Research
NexPoint (NREF) delivered earnings and revenue surprises of 5.13% and 285.92%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
NexPoint (NREF) is on the Move, Here's Why the Trend Could be Sustainable
by Zacks Equity Research
NexPoint (NREF) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.
Here's Why "Trend" Investors Would Love Betting on NexPoint (NREF)
by Zacks Equity Research
NexPoint (NREF) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.
Can NexPoint (NREF) Run Higher on Rising Earnings Estimates?
by Zacks Equity Research
NexPoint (NREF) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
NexPoint (NREF) Beats Q4 Earnings and Revenue Estimates
by Zacks Equity Research
NexPoint (NREF) delivered earnings and revenue surprises of 3.85% and 57.47%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate NexPoint (NREF) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
NexPoint (NREF) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
NexPoint (NREF) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
NexPoint (NREF) delivered earnings and revenue surprises of 20.34% and 29.06%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
NexPoint (NREF) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
NexPoint (NREF) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
NexPoint (NREF) Announces Public Offering of Common Stock
by Zacks Equity Research
Net proceeds from NexPoint's (NREF) 2-million share offering is expected to be used for life science and self-storage preferred investments.
Recent Price Trend in NexPoint (NREF) is Your Friend, Here's Why
by Zacks Equity Research
If you are looking for stocks that are well positioned to maintain their recent uptrend, NexPoint (NREF) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
NexPoint (NREF) Misses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
NexPoint (NREF) delivered earnings and revenue surprises of -6.35% and -22.07%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
NexPoint (NREF) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
NexPoint (NREF) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's What Could Help NexPoint (NREF) Maintain Its Recent Price Strength
by Zacks Equity Research
NexPoint (NREF) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
NexPoint (NREF) Misses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
NexPoint (NREF) delivered earnings and revenue surprises of -1.85% and -7.67%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
NexPoint (NREF) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
NexPoint (NREF) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
NexPoint Real Estate (NREF) Prices $75M Senior Notes Due 2026
by Zacks Equity Research
NexPoint Real Estate (NREF) will use the net proceeds from the $75-million notes offering for the acquisition of investments in line with its investment strategy.
Annaly (NLY) to Report Q2 Earnings: What's in the Offing?
by Zacks Equity Research
While lower increase rates are expected to have reduced Annaly's (NLY) borrowing costs, a decline in mortgage rates is anticipated to have impacted conditional prepayment rate and asset yield in Q2.
New Strong Buy Stocks For July 23rd
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today:
Factors to Impact New York Mortgage Trust's (NYMT) Q1 Earnings
by Zacks Equity Research
New York Mortgage Trust's (NYMT) Q1 results are expected to reflect a decline in book value and investment portfolio amid volatility in mortgage and credit markets during the quarter.
mREIT Prospects Dim as Coronavirus Crisis Overwhelms Industry
by Devyani Chamria
Coronavirus-induced issues like illiquidity in mortgage markets, depressed asset valuations, margin calls and wider spreads have been clobbering the mREIT industry.